Not exact matches
• President Obama did not go half far enough
in lifting the ban against federal funding
for embryonic stem -
cell research.
The truth, of course, is that there are no human
embryonic stem -
cell therapies even
in clinical trial, let alone ready
for therapy, and there have been no major treatment....
Benedict argued that non-conjugal reproduction such as
in vitro fertilization had created «new problems» ¯ the freezing of human embryos,
for instance, and the selective abortion of medically implanted embryos, together with pre-implantation diagnosis,
embryonic stem -
cell research, and attempts at human cloning.
research; since most of the reports have concentrated on justifying the creation of cloned human embryos
for research into and treatment of neurodegenerative diseases such as Parkinson's, «
stem -
cells» has become synonymous with «
embryonic stem -
cells»
in the public imagination.
For most
in the scientific community, the debate was never truly about whether adult
stem cells or
embryonic stem cells would be the most useful therapeutically or whether we could obtain
embryonic - like
stem cells without destroying embryos.
However,
embryonic stem cells remain the «gold standard,» and studies of all types of
stem cells should continue
in parallel
for the foreseeable future.»
(i) a woman's right to an abortion; (iii) medical immunization of teen girls (and boys) against HPV; (iv) assisted suicide; (vi) gay marriage; (vii) my right to view art and theatre deemed «offensive,» «blasphemous» or «obscene» Catholics; (viii) basic $ ex education
for older school children; (ix) treating drug abuse as principally a medical issue; (x) population control; (xi) buying alcohol on a Sunday
in many places; (xii) use of condoms and other contraceptives; (xiii)
embryonic stem cell research; (xiv) little 10 year - old boys joining organizations such as the Boy Scouts of America, regardless of the religious views of their parents; and (xv) gays being allowed to serve openly
in the military.
Sullivan went on to suggest that Chaput is using a double standard
in the 2008 election by criticizing Catholic supporters of Barack Obama, while turning a blind eye to John McCain's support
for embryonic stem cell research.
In 2005, before a Congressional hearing in the U.S., Prof. George Q. Daley of Harvard spoke forcefully and influentially about the necessity for embryonic stem - cell research to go ahead, and dismissed suggestions that one could work instead with «induced pluripotent stem cells» («iPS», i.e. stem cells reprogrammed from some cells of a living adult
In 2005, before a Congressional hearing
in the U.S., Prof. George Q. Daley of Harvard spoke forcefully and influentially about the necessity for embryonic stem - cell research to go ahead, and dismissed suggestions that one could work instead with «induced pluripotent stem cells» («iPS», i.e. stem cells reprogrammed from some cells of a living adult
in the U.S., Prof. George Q. Daley of Harvard spoke forcefully and influentially about the necessity
for embryonic stem -
cell research to go ahead, and dismissed suggestions that one could work instead with «induced pluripotent
stem cells» («iPS», i.e.
stem cells reprogrammed from some
cells of a living adult).
Yet just such an unlikely resolution may be
in hand
for one of the most acrimonious conflicts of recent times: the debate over human
embryonic stem cells....
The increasing use of
in - vitro - fertilisation techniques, and the emergence of new possibilities involving human cloning, mixing of human and animal genetic elements, and the use of
embryonic stem cells for research, among other things, brought the need
for further teaching.
(
In many ways it is worse than when John Edwards said in 2004 that if people voted for John Kerry, people like Christopher Reeve would get out of their wheelchairs and walk from embryonic stem cell therapies
In many ways it is worse than when John Edwards said
in 2004 that if people voted for John Kerry, people like Christopher Reeve would get out of their wheelchairs and walk from embryonic stem cell therapies
in 2004 that if people voted
for John Kerry, people like Christopher Reeve would get out of their wheelchairs and walk from
embryonic stem cell therapies.)
For example, ten or twenty years from now, the physician's tools may include embryonic stem cells or products obtained from cloned embryos and fetuses gestated for that purpose, making physicians who provide such treatments complicit in the life destruction required to obtain the modaliti
For example, ten or twenty years from now, the physician's tools may include
embryonic stem cells or products obtained from cloned embryos and fetuses gestated
for that purpose, making physicians who provide such treatments complicit in the life destruction required to obtain the modaliti
for that purpose, making physicians who provide such treatments complicit
in the life destruction required to obtain the modalities.
The researchers detected this SMN long noncoding RNA, or lnc - RNA (pronounced «link RNA»)
for short,
in human
embryonic kidney
cells, brain
cell samples and neurons derived from the
stem cells of healthy people and those with spinal muscular atrophy type I and II.
«We've shown that SIF - seq can be used to identify enhancers active
in cardiomyocytes, neural progenitor
cells, and
embryonic stem cells, and we think that it has the potential to be expanded
for use
in a much wider variety of
cell types,» Dickel says.
For example, a consortium of research groups called the London Project to Cure Blindness aims to test RPE transplants from
embryonic stem cells in patients with macular degeneration this year.
The study results were found using mouse
embryonic stem cells, which are good
cell models
for the study of processes seen
in human
stem cells.
In granting an injunction to two scientists who oppose widening US government funding
for research on human
embryonic stem cells (hESCs), Judge Royce Lamberth wrote of «simply preserving the status quo».
Advanced
Cell Technology, based in Santa Monica California, is developing embryonic stem cell therapies for macular degeneration and other conditions using cells obtained non-destructively from an early embryo called a blastoc
Cell Technology, based
in Santa Monica California, is developing
embryonic stem cell therapies for macular degeneration and other conditions using cells obtained non-destructively from an early embryo called a blastoc
cell therapies
for macular degeneration and other conditions using
cells obtained non-destructively from an early embryo called a blastocyst.
ACT's announcement stoked fears that scientists were trying to clone humans
for reproductive purposes — and conflated reproductive cloning and human -
embryonic -
stem -
cell research
in many people's minds.
«I think this is the best option we have ever had,» says Renee Reijo Pera, director of Stanford University's Center
for Human
Embryonic Stem Cell Research and Education
in California, who wasn't involved
in the study.
Peter Coffey, a
stem -
cell biologist at the Institute of Ophthalmology
in London, is developing an
embryonic -
stem -
cell treatment
for macular degeneration with the global drug company Pfizer.
Base oxidation regulates gene activity
In cooperation with colleagues at LMU, as well as researchers based in Berlin, Basel and Utrecht, Carell and his group have now shown, for the first time, that a standard base other than cytosine is also modified in embryonic stem cells of mic
In cooperation with colleagues at LMU, as well as researchers based
in Berlin, Basel and Utrecht, Carell and his group have now shown, for the first time, that a standard base other than cytosine is also modified in embryonic stem cells of mic
in Berlin, Basel and Utrecht, Carell and his group have now shown,
for the first time, that a standard base other than cytosine is also modified
in embryonic stem cells of mic
in embryonic stem cells of mice.
For example, animal studies have shown that neurons derived
in the lab from human
embryonic stem cells improve Parkinson's symptoms; however, any residual
stem cells associated with those neurons could form masses of unwanted
cells.
Starting
in 2007,
in the same French Institute of Health and Medical Research (INSERM) lab where he did his Ph.D., Catelain worked to harness the potential of
embryonic stem cells for treating cardiac diseases.
«Perhaps there are some mammary gland
stem cells that can be coaxed to have a slightly broader potential than normal, but I very much doubt that
embryonic - like
cells normally exist
in the breast,» says Robin Lovell - Badge of the National Institute
for Medical Research
in London.
They then argue that «By creating a financial incentive
for embryonic stem cell research — an incentive that by NIH's own admission involves investments of «hundreds of millions of dollars» — and by specifying the precise means by which embryos must be destroyed
in order to qualify
for federal funding, the NIH necessarily and knowingly subjects embryos to a substantial risk of injury or death.»
In addition, where
cells derived from
embryonic stem cells are great at proliferating — a potentially critical feature if one wants to grow sufficient numbers of
cells for clinical use — ones from the iPS lines were much feebler.
Yoshiki Sasai at the RIKEN Center
for Developmental Biology
in Kobe, Japan, and colleagues encouraged
embryonic stem cells to develop into retinal
cells, and then grew them alongside a protein matrix to promote the formation of tissue.
Although British researchers had discovered
embryonic stem cells in laboratory animals
in 1981, it wasn't until 1998 that a Wisconsin team announced it had isolated
stem cells from human embryos
for the first time.
They showed that ZIKV infection of cortical progenitors (
stem cells for cortical neurons) controlling neurogenesis triggers a stress
in the endoplasmic reticulum (where some of the cellular proteins and lipids are synthetized)
in the
embryonic brain, inducing signals
in response to incorrect protein con - formation (referred to as «unfolded protein response»).
The patch is made of eye
cells made from human
embryonic stem cells, and it has been designed
for treating the «dry» form of macular degeneration, which accounts
for 90 per cent of all cases, and affects 1.7 million people
in the US.
Others
in that camp suggest that reprogrammed adult
cells, (induced pluripotent, or iPSCs) can effectively replace the need
for pluripotent
embryonic stem cells.
But a number of the invited speakers, including Alan Trounson, president of the California Institute
for Regenerative Medicine
in San Francisco, and keynote speaker George Daley, a
stem -
cell scientist at Children's Hospital Boston
in Massachusetts, are involved
in research using human
embryonic stem cells, which the Catholic Church considers unethical.
Recently, however, I was alarmed to hear that my fellow Delawareans voted to oust Representative Mike Castle, a solid moderate who pushed
for embryonic stem cell research and was handily elected as the Republican representative of a largely Democratic state
for nine consecutive terms,
in favor of Christine O'Donnell, who, as far as I can tell, is a houseplant.
In the past year, the South Korean Food and Drug Administration (FDA) has approved the world's first three stem - cell treatments — Hearticellgram - AMI, Cupistem and Cartistem — which followed on the heels of clinical tests for human embryonic stem - cell therapies approved in 2010, according to the health ministr
In the past year, the South Korean Food and Drug Administration (FDA) has approved the world's first three
stem -
cell treatments — Hearticellgram - AMI, Cupistem and Cartistem — which followed on the heels of clinical tests
for human
embryonic stem -
cell therapies approved
in 2010, according to the health ministr
in 2010, according to the health ministry.
The immediate payoff was a commercialization deal
in age - related macular degeneration
in which Pfizer became the first big pharma company to make a move into the use of
embryonic stem cells as the basis
for a tissue regeneration therapy.
«We can work with any
embryonic stem cell line from any source and are not restricted to working with the very small number of federally approved lines as is the case
for researchers
in the United States,» says Minger.
In late 2004, California voters approved Proposition 71, allocating $ 3 billion over 10 years, making California the largest single funder of embryonic and pluripotent stem cell research in the world and consequently one of the strongest job markets for regenerative researc
In late 2004, California voters approved Proposition 71, allocating $ 3 billion over 10 years, making California the largest single funder of
embryonic and pluripotent
stem cell research
in the world and consequently one of the strongest job markets for regenerative researc
in the world and consequently one of the strongest job markets
for regenerative research.
This set the stage
for a relatively restrictive environment
for embryonic (although not adult)
stem cell research
in the United States relative to some other countries — the National Institutes of Health currently funds between about $ 600 miilion to $ 700 million a year
in stem cell research.
The laboratory process, described
in the journal Scientific Reports, entails genetically modifying a line of human
embryonic stem cells to become fluorescent upon their differentiation to retinal ganglion
cells, and then using that
cell line
for development of new differentiation methods and characterization of the resulting
cells.
In this way they act like
embryonic stem cells and share their revolutionary therapeutic potential — and as such, they could eliminate the need
for using and then destroying human embryos.
In addition to providing an alternative to embryonic stem cells for potential use in regenerating diseased tissues, iPS cells are being used to learn more about diseases, especially diseases driven by mutated gene
In addition to providing an alternative to
embryonic stem cells for potential use
in regenerating diseased tissues, iPS cells are being used to learn more about diseases, especially diseases driven by mutated gene
in regenerating diseased tissues, iPS
cells are being used to learn more about diseases, especially diseases driven by mutated genes.
Further investigation, says Resar, showed that these unusual properties arise from the ability of HMGA1 to turn on several genes involved
in the Wnt pathway, a network of proteins necessary
for embryonic development and
stem cell activity.
Starting
in the mid-2000s, Yoshiki Sasai's team at the RIKEN Center
for Developmental Biology
in Kobe, Japan, demonstrated how to grow brainlike structures using
embryonic stem cells, first from mice and then humans.
In 1998, scientists figured out how to derive human
embryonic stem cells (ESCs)
for medical research, and the method kicked off an intense debate.
For the purpose of additional experiments, the researchers generated myocardial
cells from
embryonic stem cells and human skin
cells,
in collaboration with the lab headed by Prof Dr Jürgen Hescheler at the University of Cologne.
Stem cell advocates have been expressing serious worry that ethical requirements spelled out in the draft guidelines — in particular, informed consent procedures for embryo donors — will rule out the use of many existing human embryonic stem cell lines, including the 21 lines approved under the Bush Administrat
Stem cell advocates have been expressing serious worry that ethical requirements spelled out
in the draft guidelines —
in particular, informed consent procedures
for embryo donors — will rule out the use of many existing human
embryonic stem cell lines, including the 21 lines approved under the Bush Administrat
stem cell lines, including the 21 lines approved under the Bush Administration.
The final guidelines on research with human
embryonic stem cells issued on Monday by the National Institutes of Health set out criteria
for determining which ES
cell lines can be used
in federally funded experiments and give NIH discretion to approve old lines that don't meet stringent modern ethical requirements.
His postdoc characterizing human
embryonic stem cells resulted
in seven papers and a contract position at the Center
for Cancer Systems Biology at Tufts University School of Medicine
in 2009.